X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CANCER SCIENCE

期刊標題檢索 CANCER SCI 最新評論: Part2: Quality control in the process is also lacking. Not only are t... (2024-06-18)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CANCER SCIENCE]您好,您是該頁面的第 138111 位訪客。

期刊簡介
期刊名稱CANCER SCIENCE CANCER SCIENCE
LetPub Score
7.5
50 ratings
Rate

Reputation
8.2

Influence
6.7

Speed
9.2

期刊簡稱CANCER SCI
ISSN1347-9032
E-ISSN1349-7006
h-index129
CiteScore
CiteScoreSJRSNIPCiteScore Rank
9.901.6251.091
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q161 / 404
Category: Medicine
Subcategory: Cancer Research
Q152 / 230

自引率 (2023-2024)2.20%自引率趨勢
掲載範囲
Cancer Science (formerly Japanese Journal of Cancer Research) is a monthly publication of the Japanese Cancer Association. First published in 1907, the Journal continues to publish original articles, editorials, and letters to the editor, describing original research in the fields of basic, translational and clinical cancer research. The Journal also accepts reports and case reports.

Cancer Science aims to present highly significant and timely findings that have a significant clinical impact on oncologists or that may alter the disease concept of a tumor. The Journal will not publish case reports that describe a rare tumor or condition without new findings to be added to previous reports; combination of different tumors without new suggestive findings for oncological research; remarkable effect of already known treatments without suggestive data to explain the exceptional result. Review articles may also be published.
官方網站http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1349-7006
在線稿件提交http://mc.manuscriptcentral.com/cas
開放訪問Yes
出版商Wiley-Blackwell
主題領域医学
出版國/地區JAPAN
發行頻率月刊
創刊年2003
每年文章數316每年文章數趨勢
黃金OA百分比73.61%
OA Related Info
APC: Yes( USD2600; GBP1650; EUR2350; )
APC waiver:Check Notes
Other charges: No
Keywords: oncology、cancer research、palliative care、radiotherapy
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ178/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1347-9032%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: About 2.0 month(s)
競爭力 *來自作者的數據: About 62.5%
參考鏈接
相關期刊 【CANCER SCIENCE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS326096
    CANCER RESEARCH310906
    BMC CANCER242780
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH197871
    INTERNATIONAL JOURNAL OF CANCER188171
    Asian Pacific Journal of Cancer Prevention184123
    CLINICAL CANCER RESEARCH180933
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY171556
    ONCOLOGY REPORTS171145
    CA-A CANCER JOURNAL FOR CLINICIANS163243
  •  

    CANCER SCIENCE CANCER SCIENCE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CANCER SCIENCE] 的評論撰寫評論
作者: shanzhenxieqi


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2024-06-18 08:14:08 評論於
Part2: Quality control in the process is also lacking. Not only are the issues not clearly stated at once, requiring multiple revisions of the formatting, but also the statements are inconsistent. For example, it was mentioned once to include author contributions in the declaration, and later it was said to list them separately. In addition, the requirements for word count and images are inconsistent. Finally, this journal has strict limits on word count and number of references. For a review submission, no more than 80 references are allowed, and the total word count (including references, figures, statements, title page, etc.) must not exceed 5000. I already have over 2000 words with 74 references. This means that if you have many references, you can only write up to 2000 words. What can you write in a review of 2000 words? When I checked the journal's website, I found a recent review article with around 7000 words and an excessive number of references. But others can exceed the limits while you cannot. You have to follow the requirements. However, the instructions from this journal are unclear. The submission guidelines on the website say it's okay to exceed the word limit, just mention it in the cover letter. It didn't specify how much you can exceed. But after submission, the tone changed, saying no more than 500 words. Why didn't you mention it earlier? Can't you modify the submission guidelines? I wasted four months on this journal for nothing and feel like dying. I will never submit again, especially review articles, as it's infuriating
(0) 讚! | shanzhenxieqi

作者: shanzhenxieqi


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2024-06-18 07:58:01 評論於
The associate editor I was assigned to was particularly disgusting. After submitting my manuscript, the reviewer gave some minor comments, but the associate editor did not provide any feedback for minor revisions. I responded very seriously later, but after waiting for a long time, the associate editor said that I did not fully comply with the reviewer's comments, without any other explanation, and requested a revision. The reality is that the reviewer misunderstood and I had explained very seriously before. I had to make modifications again, this time following the reviewer's comments completely, but after waiting for a long time again, the associate editor sent back comments saying that he did not mean that, and brought up many suggestions that could have been mentioned in the previous two rounds of revisions, as well as some unreasonable suggestions, and demanded major revisions. We made serious modifications and provided responses again, including redrawing Figure 1 and making many modifications according to this associate editor's suggestions. However, the associate editor claimed that there was an error in the orientation of Figure 1, which would have a "fatal impact" on readers, and rejected the manuscript solely based on this reason, without providing any further explanation. I later carefully reviewed and checked a lot of literature and materials, confirming that the figure was indeed correct, but unfortunately, the manuscript had already been rejected
(0) 讚! | shanzhenxieqi

作者: 海滨


領域: 医学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2023-02-22 00:19:24 評論於
The reviewer's comments are very pertinent. The first review took one and a half months, minor revisions took two months, and acceptance was received three weeks later.
(0) 讚! | 海滨

作者: lssds


領域: 医学
審稿時間: 2.0 month(s)
結果: 拒稿


撰寫評論

2020-06-16 15:09:09 評論於
The review speed is average. It focuses on clinical direction, and hardly accepts articles on preclinical research. The publication fee is about 15,000 RMB. The level of the reviewers is ordinary.

(2) 讚! | lssds

作者: Peggy


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2020-04-22 16:42:22 評論於
There were very strict format requirements on the journal, and the efficiency was very high. The first review lasted for 1 month and major revisions were recommended. The revised manuscript was submitted two and a half months later. The second review lasted for 21 days. Minor revisions were recommended. The revised manuscript was submitted 20 days later and it was accepted the next day.

(1) 讚! | Peggy

作者: 考拉


領域: 生命科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2018-05-28 17:50:03 評論於
I feel that I have nothing to do.The format is in accordance with the submission requirementsGenerally not card you
(0) 讚! | 考拉

作者: Anonymous


領域: 医药科学
審稿時間: 4.0 month(s)
結果: 修改後接受


撰寫評論

2016-09-01 10:21:11 評論於
has a higher format requirement for the article.
(1) 讚! | Anonymous

作者: 匿名


領域: 医药科学
審稿時間: 0.0 month(s)
結果:


撰寫評論

2011-09-03 11:07:00 評論於
Received a reply after 23 days of submission in December 2010. After two months of minor repair, I returned to the journal and accepted it within one week. It lasted for 100 days, and it was quite smooth.
(0) 讚! | 匿名

作者: 匿名


領域: 肿瘤发生机制
審稿時間: 0.0 month(s)
結果:


撰寫評論

2010-08-24 22:25:00 評論於
Requirements for this journal are not as high as others in the field, and the editorial staff is very professional and helpful. You can actually ask questions and receive timely responses! The fee is $50 per page.

(0) 讚! | 匿名

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CANCER SCIENCE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*